| Page 1563 | Kisaco Research
 

Stephanie Boon

Founder
Wondercide

Stephanie Boon

Founder
Wondercide

Stephanie Boon

Founder
Wondercide
 

Barry Brackner

Strategy Consultant

Barry is a strategy consultant to the pharma, welfare, retail, tech and veterinary profession having previously held senior executive roles within the veterinary profession most recently an executive board role at CVS as Marketing and Commercial Director, the largest PLC veterinary group in Europe, a role which involved him developing and delivering marketing strategies for the organisation and its member practices and honing its commercial operations.

Barry Brackner

Strategy Consultant

Barry Brackner

Strategy Consultant

Barry is a strategy consultant to the pharma, welfare, retail, tech and veterinary profession having previously held senior executive roles within the veterinary profession most recently an executive board role at CVS as Marketing and Commercial Director, the largest PLC veterinary group in Europe, a role which involved him developing and delivering marketing strategies for the organisation and its member practices and honing its commercial operations. This role saw him supporting growth and the integration of over 300 veterinary practices, crematoria, out of hours clinics and multi-disciplinary hospitals and bringing to market a number of own label prescription and non-prescription products.

 

Rachel Rodgers

Founder
Hairy Dog Marketing

Rachel Rodgers

Founder
Hairy Dog Marketing

Rachel Rodgers

Founder
Hairy Dog Marketing
 

Mathew Prior

CEO
Trusted Housesitters

Mathew is CEO of TrustedHousesitters, the world’s largest marketplace dedicated to vacation pet care. He has a successful background in growing global experiential leisure businesses.

Mathew Prior

CEO
Trusted Housesitters

Mathew Prior

CEO
Trusted Housesitters

Mathew is CEO of TrustedHousesitters, the world’s largest marketplace dedicated to vacation pet care. He has a successful background in growing global experiential leisure businesses.

 

Veronique Glorieux

CEO
Eat Small

Veronique Glorieux

CEO
Eat Small

Veronique Glorieux

CEO
Eat Small
Interview with Richard Alm, Director of Alliances, CARB-X
Interview with Richard Alm
 

Lindsay Meyers

Director of Product Development & Veterinary Channel
Primal Pet Food

Lindsay Meyers

Director of Product Development & Veterinary Channel
Primal Pet Food

Lindsay Meyers

Director of Product Development & Veterinary Channel
Primal Pet Food
 

Liz Barton

Senior Account Manager
Companion Consultancy

Liz has had a varied career as a clinical vet and has diversified into PR and marketing for animal health companies. She brings a broad understanding of the industry and the dynamics of working with people, pets and livestock to achieve the best outcomes.

Liz Barton

Senior Account Manager
Companion Consultancy

Liz Barton

Senior Account Manager
Companion Consultancy

Liz has had a varied career as a clinical vet and has diversified into PR and marketing for animal health companies. She brings a broad understanding of the industry and the dynamics of working with people, pets and livestock to achieve the best outcomes.

 

Mark Heffernan

CEO
Scout Bio

Scout Bio’s CEO, Mark Heffernan, has nearly two decades of experience in human biotechnology start-ups and animal health R&D.  As a founding partner and CEO, Heffernan has raised over $150,000,000 in private and public capital raisings and built successful global teams to execute drug discovery and development, including Nexvet Biopharma, which was sold to Zoetis in July 2017.  Dr. Heffernan also serves as CEO for Stonehaven Incubate, a Switzerland-based incubator of translational opportunities to bring promising human technologies into animal health applications.

Mark Heffernan

CEO
Scout Bio

Mark Heffernan

CEO
Scout Bio

Scout Bio’s CEO, Mark Heffernan, has nearly two decades of experience in human biotechnology start-ups and animal health R&D.  As a founding partner and CEO, Heffernan has raised over $150,000,000 in private and public capital raisings and built successful global teams to execute drug discovery and development, including Nexvet Biopharma, which was sold to Zoetis in July 2017.  Dr. Heffernan also serves as CEO for Stonehaven Incubate, a Switzerland-based incubator of translational opportunities to bring promising human technologies into animal health applications.